Adjuvant therapy in node-positive vulvar cancer

Expert Review of Anticancer Therapy

Volumn 13, Issue 7, 2013, Pages 839-844

  Mahner, Sven ^a   Trillsch, Fabian ^a   Kock, Lilli ^a   Rohsbach, Donata ^a   Petersen, Cordula ^a   Kruell, Andreas ^a   Harter, Philipp ^b   Jaenicke, Fritz ^a   Woelber, Linn ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

adjuvant therapy; chemoradiation; future trials; neoadjuvant treatment; perspectives; radiation; vulvar cancer

Indexed keywords

CISPLATIN;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NODE POSITIVE VULVAR CANCER; PELVIS LYMPHADENECTOMY; RADIATION RESPONSE; RECURRENT CANCER; REVIEW; TREATMENT INDICATION; TUMOR INVASION; VULVA CANCER; VULVECTOMY;

EID: 84880826308     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2013.811063     Document Type: Review

References (52)

1. Beller U, Quinn MA, Benedet JL et al. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95(Suppl. 1), S7-27 (2006
2. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet. Gynecol. 107(5), 1018-1022 (2006
3. Hampl M, Kueppers V, Bender HG. Single large inguinal lymph node metastasis in human papillomavirus-induced early invasive vulvar cancer of the anterior fourchette in two young women. Gynecol. Obstet. Invest. 67(1), 42-45 (2009
4. Joura EA, Lösch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J. Reprod. Med. 45(8), 613-615 (2000
5. Messing MJ, Gallup DG. Carcinoma of the vulva in young women. Obstet. Gynecol. 86(1), 51-54 (1995
6. Hampl M, Hantschmann P, Michels W, Hillemanns P; German Multicenter Study Group. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: Results of a multicenter study in Germany. Gynecol. Oncol. 111(2), 282-288 (2008
7. Beriwal S, Coon D, Heron DE et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol. Oncol. 109(2), 291-295 (2008
8. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin. Radiat. Oncol. 16(3), 144-151 (2006
9. Moran MS, Castrucci WA, Ahmad M et al. Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes. Int. J. Radiat. Oncol. Biol. Phys. 76(4), 1026-1036 (2010
10. Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW. Adjuvant radiation for vulvar carcinoma: Improved local control. Int. J. Radiat. Oncol. Biol. Phys. 38(2), 381-389 (1997
11. Wittekind C, Meyer HJ, Bootz F, Wagner G. TNM Klassifikation Maligner Tumoren. Springer, Berlin, Germany (2002
12. DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am. J. Obstet. Gynecol. 133(7), 825-832 (1979
13. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: Further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol. Oncol. 57(2), 215-220 (1995
14. Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: A randomized controlled trial. Obstet. Gynecol. 114(3), 537-546 (2009
15. Woelber L, Choschzick M, Eulenburg C et al. Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva. Ann. Surg. Oncol. 18(13), 3811-3818 (2011
16. Chan JK, Sugiyama V, Pham H et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: A multivariate analysis. Gynecol. Oncol. 104(3), 636-641 (2007
17. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: Further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol. Oncol. 57(2), 215-220 (1995
18. De Hullu JA, Hollema H, Lolkema S et al. Vulvar carcinoma. The price of less radical surgery. Cancer 95(11), 2331-2338 (2002
19. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol. Oncol. 38(3), 309-314 (1990
20. Groenen SM, Timmers PJ, Burger CW. Recurrence rate in vulvar carcinoma in relation to pathological margin distance. Int. J. Gynecol. Cancer 20(5), 869-873 (2010
21. Höckel M, Schmidt K, Bornmann K, Horn LC, Dornhöfer N. Vulvar field resection: Novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol. Oncol. 119(1), 106-113 (2010
22. Catanzarite T, Neubauer N, Doll K, Singh D, Schink J, Lurain J. Margin status as predictor of recurrence in squamous cell carcinoma of the vulva: Challenging the 8 millimeter rule. IGCS, Vancouver, BC, Canada (2012
23. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol. Oncol. 57(3), 327-334 (1995
24. Woelber L, Mahner S, Voelker K et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res. 29(2), 545-552 (2009
25. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int. J. Radiat. Oncol. Biol. Phys. 57(2), 409-418 (2003
26. Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet. Gynecol. 113(4), 895-901 (2009
27. Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ. Local relapse in patients treated for squamous cell vulvar carcinoma: Incidence and prognostic value. Obstet. Gynecol. 100(6), 1159-1167 (2002
28. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit. Rev. Oncol. Hematol. 60(3), 227-241 (2006
29. Woelber L, Mahner S, Voelker K et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res. 29(2), 545-552 (2009
30. Stehman FB, Bundy BN, Thomas G et al. Groin dissection versus groin radiation in carcinoma of the vulva: A Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys. 24(2), 389-396 (1992
31. Oonk MH, van Hemel BM, Hollema H et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: Results from GROINSS-V, a multicentre observational study. Lancet Oncol. 11(7), 646-652 (2010
32. Van Der Velden J, van Lindert AC, Lammes FB et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75(12), 2885-2890 (1995
33. Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol. Oncol. 95(3), 701-705 (2004
34. Paladini D, Cross P, Lopes A, Monaghan JM. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 74(9), 2491-2496 (1994
35. Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol. Oncol. 45(3), 313-316 (1992
36. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet. Gynecol. 68(6), 733-740 (1986
37. Fons G, Groenen SM, Oonk MH et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol. Oncol. 114(2), 343-345 (2009
38. Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet. Gynecol. 61(4), 408-412 (1983
39. Curry SL, Wharton JT, Rutledge F. Positive lymph nodes in vulvar squamous carcinoma. Gynecol. Oncol. 9(1), 63-67 (1980
40. Klemm P, Marnitz S, Köhler C, Braig U, Schneider A. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol. Oncol. 99(1), 101-105 (2005
41. Oonk MH, de Hullu JA, Van Der Zee AG. Current controversies in the management of patients with early-stage vulvar cancer. Curr. Opin. Oncol. 22(5), 481-486 (2010
42. Knopp S, Holm R, TropéC, Nesland JM. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol. Oncol. 99(2), 383-387 (2005
43. Narayansingh GV, Miller ID, Sharma M et al. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br. J. Cancer 92(2), 222-224 (2005
44. Woelber L, Eulenburg C, Choschzick M et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int. J. Gynecol. Cancer 22(3), 503-508 (2012
45. Parthasarathy A, Cheung MK, Osann K et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol. Oncol. 103(3), 1095-1099 (2006
46. Mahner S, Jueckstock JK, Hilpert F et al. Impact of adjuvant therapy in lymph-node positive vulvar cancer: The AGO CARE 1 study. J. Clin. Oncol. 30(Suppl.), Abstract 5007 (2012
47. Bellati F, Angioli R, Manci N et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol. Oncol. 96(1), 227-231 (2005
48. Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int. J. Radiat. Oncol. Biol. Phys. 47(5), 1235-1244 (2000
49. Moore DH, Koh WJ, McGuire WP, EJ W. Vulva. In: Principles and Practices of Gynecologic Cancers. Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME (Eds). Lippincott Williams &Wilkins, Philadelphia, PA, USA (2005
50. Hoffman MS. Squamous-cell carcinoma of the vulva: Locally advanced disease. Best Pract. Res. Clin. Obstet. Gynaecol. 17(4), 635-647 (2003
51. Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: A Phase II study of the Gynecologic Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 42(1), 79-85 (1998
52. Moore DH, Ali S, Koh WJ et al. A Phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-Advanced squamous cell carcinoma of the vulva: A Gynecologic Oncology Group study. Gynecol. Oncol. 124(3), 529-533 (2012